PwC Event – 5. Schweizer MWST-Tagung – 05. November 2020, Bellevue Palace Bern

Die Mehrwertsteuer, insbesondere im Pharma Bereich für Konzerne, KMUs und Start-ups, ist im steten Wandel und immer transparenter.

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben / Neuerungen effizient und kostengünstig einzuhalten. Dazu kommt die aktuelle COVID-19 Situation, welche umsatzsteuerliche Herausforderungen mit sich bringt und die es zu meistern gilt. Gleichzeitig spielt Industrie 4.0, die umfassende Digitalisierung der industriellen Produktion, die den absehbaren Wandel herbeiführt, aber auch neue Chancen zur Prozessoptimierung bietet, eine immer wichtigere Rolle.

Continue reading PwC Event – 5. Schweizer MWST-Tagung – 05. November 2020, Bellevue Palace Bern

Last chance to register for our PwC event “4. Schweizer MWST-Tagung” in our beautiful capital Bern

Why should you as a pharma & life sciences company register to the event?

… because:

  • you will gathering insights on relevant topics of the Swiss VAT authorities – directly from the competent officer of the Federal Tax Administration (FTA)
  • you strive to be prepared as per 1 January 2020 regarding the EU VAT Quick Fixes and its implications e.g. for pharma & life sciences companies
Continue reading Last chance to register for our PwC event “4. Schweizer MWST-Tagung” in our beautiful capital Bern

Do you apply the correct VAT rate on your Pharma, Life Science and Medtech products?

Welcome back from the summer break.

VAT rates change continually in the European Union and the rest of the world
(e.g. this year’s VAT changes: Lebanon increase to 11%, Liechtenstein and Switzerland cut to 7.7%, Saudi Arabia introduction of 5%, etc.).

It is crucial to apply for the correct VAT rate (standard, reduced, super reduced rate, possible exemption), in order to comply with the local rules and regulations, benefit from possible optimizations (cash flow, input VAT deduction, correct pricing etc.) and minimize the risk of reputational damage.

For example in some countries like Ireland, your medtech products might be exempt from VAT with the possibility of respective cash flow optimizations approaches.

The further question that has to be addressed in that regard is:

On which basis do you define which VAT rate / possible exemption does apply?

Here the Customs Tariff number is key. The definition of the correct Customs Tariff number leads to the correct VAT rate application of your products. Please take into consideration the differences in the regions, e.g. 4 digit global harmonization but differences in the Sub headings – e.g. 1 digit in Switzerland / 2 digits in the European Union.

Recommendation

I highly recommend to review the application of the VAT rates of your products and the respective implementation in the master data of your ERP system on a regular basis – especially in the course of a possible ERP change (S/4HANA) and/or a new supply chain implementation.